September 2024

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

2024 /

Vancouver, British Columbia and Rehovot, Israel – September 20, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company’s management team, continuing to serve as Vice President of Investor Relations of […]

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board Read More »

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

2024 /

Vancouver, British Columbia and Rehovot, Israel – September 12, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024. CEO Ilan Sobel

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024 Read More »

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

2024 /

Vancouver, British Columbia and Rehovot, Israel – September 4, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 – 10, 2024 at the Lotte New

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference Read More »